Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-30
DOI
10.1038/s41598-020-64408-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A microbial-based cancer vaccine for induction of EGFRvIII-specific CD8+ T cells and anti-tumor immunity
- (2019) Lauren Zebertavage et al. PLoS One
- Impact of epitope density on CD8+ T cell development and function
- (2019) Gabriela L. Cosma et al. MOLECULAR IMMUNOLOGY
- An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
- (2019) Marian L. Burr et al. CANCER CELL
- Mechanisms of resistance to immune checkpoint inhibitors
- (2018) Russell W Jenkins et al. BRITISH JOURNAL OF CANCER
- An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
- (2018) Jianfang Liu et al. CELL
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- Tumor cure by radiation therapy and checkpoint inhibitors depends on pre-existing immunity
- (2018) Marka R. Crittenden et al. Scientific Reports
- Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- ATR kinase inhibitor AZD6738 potentiates CD8+ T cell–dependent antitumor activity following radiation
- (2018) Frank P. Vendetti et al. JOURNAL OF CLINICAL INVESTIGATION
- Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer
- (2018) Ephraim S. Tang et al. JAMA Surgery
- Modulation of Naive CD8 T Cell Response Features by Ligand Density, Affinity, and Continued Signaling via Internalized TCRs
- (2017) Renu Balyan et al. JOURNAL OF IMMUNOLOGY
- Mitotic progression following DNA damage enables pattern recognition within micronuclei
- (2017) Shane M. Harding et al. NATURE
- Salmon provides fast and bias-aware quantification of transcript expression
- (2017) Rob Patro et al. NATURE METHODS
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
- (2017) Claire Vanpouille-Box et al. Nature Communications
- Suppression of Type I IFN Signaling in Tumors Mediates Resistance to Anti-PD-1 Treatment That Can Be Overcome by Radiotherapy
- (2016) Xiaohong Wang et al. CANCER RESEARCH
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity
- (2016) Stephan Halle et al. IMMUNITY
- Multispectral Imaging of T and B Cells in Murine Spleen and Tumor
- (2016) Zipei Feng et al. JOURNAL OF IMMUNOLOGY
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- NLRC5/MHC class I transactivator is a target for immune evasion in cancer
- (2016) Sayuri Yoshihama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance
- (2016) Wenxin Zheng et al. Oncotarget
- Antitumor Efficacy of Radiation plus Immunotherapy Depends upon Dendritic Cell Activation of Effector CD8+ T Cells
- (2016) S. J. Dovedi et al. Cancer Immunology Research
- NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8+ T lymphocytes
- (2016) Galaxia M. Rodriguez et al. OncoImmunology
- Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
- (2015) Christina Twyman-Saint Victor et al. NATURE
- In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
- (2015) Claire Vanpouille-Box et al. VACCINE
- NLRC5 Exclusively Transactivates MHC Class I and Related Genes through a Distinctive SXY Module
- (2015) Kristina Ludigs et al. PLoS Genetics
- Acquired Resistance to Fractionated Radiotherapy Can Be Overcome by Concurrent PD-L1 Blockade
- (2014) S. J. Dovedi et al. CANCER RESEARCH
- STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
- (2014) Liufu Deng et al. IMMUNITY
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen
- (2014) A. B. Sharabi et al. Cancer Immunology Research
- Catastrophic Nuclear Envelope Collapse in Cancer Cell Micronuclei
- (2013) Emily M. Hatch et al. CELL
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Regulation of Class I Major Histocompatibility Complex (MHC) by Nucleotide-binding Domain, Leucine-rich Repeat-containing (NLR) Proteins
- (2012) Gregory R. Robbins et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NLRC5 Controls Basal MHC Class I Gene Expression in an MHC Enhanceosome-Dependent Manner
- (2012) A. Neerincx et al. JOURNAL OF IMMUNOLOGY
- NLRC5 Deficiency Selectively Impairs MHC Class I- Dependent Lymphocyte Killing by Cytotoxic T Cells
- (2012) F. Staehli et al. JOURNAL OF IMMUNOLOGY
- NLRC5 Cooperates with the RFX Transcription Factor Complex To Induce MHC Class I Gene Expression
- (2012) T. B. Meissner et al. JOURNAL OF IMMUNOLOGY
- Chemotherapeutics and Radiation Stimulate MHC Class I Expression through Elevated Interferon-beta Signaling in Breast Cancer Cells
- (2012) Shan Wan et al. PLoS One
- Evidence that the Density of Self Peptide-MHC Ligands Regulates T-Cell Receptor Signaling
- (2012) Nadia Anikeeva et al. PLoS One
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
- (2011) B. C. Burnette et al. CANCER RESEARCH
- T cell receptor signal strength in Tregand iNKT cell development demonstrated by a novel fluorescent reporter mouse
- (2011) Amy E. Moran et al. JOURNAL OF EXPERIMENTAL MEDICINE
- “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy
- (2010) Federico Garrido et al. INTERNATIONAL JOURNAL OF CANCER
- Antigen Specific In Vivo Killing Assay using CFSE Labeled Target Cells
- (2010) Marina Durward et al. Jove-Journal of Visualized Experiments
- HER-2/neu mediated down-regulation of MHC class I antigen processing prevents CTL-mediated tumor recognition upon DNA vaccination in HLA-A2 transgenic mice
- (2008) Simona Vertuani et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Regulated Expression of a Tumor-Associated Antigen Reveals Multiple Levels of T-Cell Tolerance in a Mouse Model of Lung Cancer
- (2008) A. F. Cheung et al. CANCER RESEARCH
- T-cell activation through immunological synapses and kinapses
- (2008) Michael L. Dustin IMMUNOLOGICAL REVIEWS
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started